Huiyan Zeng Selected Research

Huiyan Zeng Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 02/2003
9	Inflammation (Inflammations) 03/2013 - 12/2002
6	Down Syndrome (Down's Syndrome) 01/2022 - 11/2006
4	Pathologic Neovascularization 12/2008 - 03/2006
3	Colitis 02/2011 - 10/2004
2	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2017
2	Pain (Aches) 11/2020 - 09/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 07/2014
2	Sepsis (Septicemia) 01/2020 - 01/2019
2	Carcinogenesis 08/2017 - 06/2017
1	Non-alcoholic Fatty Liver Disease 05/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2020
1	Neuralgia (Stump Neuralgia) 11/2020
1	Albuminuria 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Endotoxemia 01/2019
1	Thrombosis (Thrombus) 06/2017
1	Liver Neoplasms (Liver Cancer) 06/2017
1	Infections 08/2012
1	Hypoxia (Hypoxemia) 08/2009
1	Colonic Neoplasms (Colon Cancer) 04/2007
1	Adenocarcinoma 02/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2003
1	Astrocytoma (Pilocytic Astrocytoma) 12/2002

Drug/Important Bio-Agent (IBA)

14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 02/2003
7	Protein Isoforms (Isoforms)IBA 01/2022 - 12/2003
6	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 03/2013
5	Member 1 Group A Nuclear Receptor Subfamily 4IBA 01/2020 - 10/2014
5	NeurotensinIBA 02/2011 - 06/2003
5	NeuropeptidesIBA 02/2011 - 12/2002
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2017
3	matrigelIBA 11/2021 - 12/2008
3	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 03/2013
3	Interleukin-8 (Interleukin 8)IBA 02/2011 - 12/2002
3	NF-kappa B (NF-kB)IBA 04/2006 - 12/2002
2	Complementary DNA (cDNA)IBA 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 04/2006
2	IntegrinsIBA 01/2019 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 07/2014 - 08/2012
2	Clostridium difficile tcdA proteinIBA 02/2011 - 10/2004
2	ErbB Receptors (EGF Receptor)IBA 02/2011 - 04/2007
2	InterleukinsIBA 06/2005 - 12/2002
1	ginsenoside RfIBA 05/2022
1	Therapeutic UsesIBA 05/2022
1	Biological ProductsIBA 05/2022
1	TriterpenesIBA 05/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	CarcinogensIBA 01/2022
1	cadherin 5IBA 11/2021
1	NAD (NADH)IBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Insulin Glargine (Lantus)FDA Link 01/2020
1	LipopolysaccharidesIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 07/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2011
1	Dextran SulfateIBA 02/2011
1	Angiogenesis InhibitorsIBA 08/2009
1	Hypoxia-Inducible Factor 1IBA 08/2009
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2009
1	Complement System Proteins (Complement)IBA 08/2009
1	CalcineurinIBA 11/2006
1	Sulfates (Sulfates, Inorganic)IBA 04/2006
1	GhrelinIBA 04/2006
1	Orphan Nuclear ReceptorsIBA 03/2006
1	Transcription Factors (Transcription Factor)IBA 03/2006
1	Neuropilin-1IBA 12/2003
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2003
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2003
1	Insulin-Like PeptidesIBA 02/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2003
1	p38 Mitogen-Activated Protein KinasesIBA 12/2002
1	Substance PIBA 12/2002
1	Mitogen-Activated Protein KinasesIBA 12/2002
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 12/2002

Therapy/Procedure

3	Therapeutics 08/2017 - 08/2009
1	Transcranial Magnetic Stimulation 09/2020
1	Ligation 01/2019
1	Punctures 01/2019